Prospective Clinical Evaluation of Three Prosthesis Re-Cap, M2a-Magnum and C2a-Taper.

This study is currently recruiting participants.

Verified by Frederiksberg University Hospital, September 2006

Sponsored by:	Frederiksberg University Hospital
Information provided by:	Frederiksberg University Hospital
ClinicalTrials.gov Identifier:	NCT00284674

Purpose

This evaluation is being conducted to evaluate the performance of thee prosthesis.

Condition	Intervention	Phase
Patients Undergoing a THR	Device: Hip prosthesis (re-cap, m2a-magnum and C2a-taper)	Phase IV

Study Type:	Interventional
Study Design:	Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study

Eligibility

Criteria

Inclusion Criteria:

Good general health of age (ASA I-II)
DEXA-scanning: lower limit for a 55 years old man
MRI normal vitality in caput
Willing to return for follow-up evaluations
Exclusion Criteria:
Subjects displaying any of the following contra-indications shall be excluded from this evaluation:
Inability to co-operate with and complete the study
Collum < 2 cm
Large cysts in caput
Mismatch between caput acetabulum
Caput necrosis

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00284674

Contacts

Contact: Arne Borgwardt, M.D.

004538163450

Locations

Denmark, Frederiksberg
Frederiksberg University Hospital	Recruiting
Copenhagen, Frederiksberg, Denmark, 2000
Contact: Arne Borgwardt, M.D. 004538163450 Arne@borgwardt.com

Sponsors and Collaborators

Frederiksberg University Hospital

Investigators

Study Director:

Arne Borgwardt, M.D.

Frederiksberg University Hospital

More Information

Study ID Numbers:	KF-01-287.591
Study First Received:	January 31, 2006
Last Updated:	September 14, 2006
ClinicalTrials.gov Identifier:	NCT00284674
Health Authority:	Denmark: Ethics Committee

ClinicalTrials.gov processed this record on January 16, 2009